IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 77 filers reported holding IMMUNOMEDICS INC in Q2 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,823,000 | +58.0% | 21,436 | -34.1% | 0.01% | +57.1% |
| Q2 2020 | $1,154,000 | -70.5% | 32,548 | -88.8% | 0.01% | -75.0% |
| Q1 2020 | $3,909,000 | -85.7% | 289,998 | -77.6% | 0.03% | -77.4% |
| Q4 2019 | $27,367,000 | +74.3% | 1,293,339 | +9.2% | 0.12% | +72.2% |
| Q3 2019 | $15,700,000 | -4.3% | 1,183,990 | +0.1% | 0.07% | -1.4% |
| Q2 2019 | $16,414,000 | +37.0% | 1,183,389 | +89.7% | 0.07% | +37.7% |
| Q1 2019 | $11,983,000 | +36.0% | 623,795 | +1.0% | 0.05% | +29.3% |
| Q4 2018 | $8,813,000 | -36.0% | 617,585 | -6.5% | 0.04% | -21.2% |
| Q3 2018 | $13,762,000 | -10.8% | 660,701 | +1.3% | 0.05% | -14.8% |
| Q2 2018 | $15,432,000 | +75.2% | 651,944 | +8.2% | 0.06% | +74.3% |
| Q1 2018 | $8,806,000 | -16.2% | 602,739 | -7.3% | 0.04% | -10.3% |
| Q4 2017 | $10,513,000 | +15.8% | 650,547 | +0.1% | 0.04% | +8.3% |
| Q3 2017 | $9,081,000 | +59.8% | 649,601 | +0.9% | 0.04% | +56.5% |
| Q2 2017 | $5,683,000 | +134.1% | 643,637 | +71.5% | 0.02% | +130.0% |
| Q1 2017 | $2,428,000 | +108.2% | 375,225 | +18.1% | 0.01% | +100.0% |
| Q4 2016 | $1,166,000 | -60.6% | 317,691 | -65.1% | 0.01% | -64.3% |
| Q3 2016 | $2,957,000 | +30.0% | 909,852 | -7.2% | 0.01% | +27.3% |
| Q2 2016 | $2,275,000 | +4.0% | 980,444 | +12.1% | 0.01% | 0.0% |
| Q1 2016 | $2,187,000 | +11.1% | 874,754 | +36.5% | 0.01% | +10.0% |
| Q4 2015 | $1,968,000 | +160.7% | 640,902 | +46.1% | 0.01% | +150.0% |
| Q3 2015 | $755,000 | -18.8% | 438,774 | +91.5% | 0.00% | -20.0% |
| Q2 2015 | $930,000 | +34.6% | 229,136 | +27.0% | 0.01% | +25.0% |
| Q1 2015 | $691,000 | -74.3% | 180,469 | -67.8% | 0.00% | -71.4% |
| Q4 2014 | $2,690,000 | +31.5% | 560,460 | +1.9% | 0.01% | +40.0% |
| Q3 2014 | $2,046,000 | +5.7% | 549,894 | +3.6% | 0.01% | +11.1% |
| Q2 2014 | $1,936,000 | +0.3% | 530,740 | +15.8% | 0.01% | 0.0% |
| Q1 2014 | $1,930,000 | -8.8% | 458,416 | -0.5% | 0.01% | -10.0% |
| Q4 2013 | $2,117,000 | -24.8% | 460,581 | +1.2% | 0.01% | -28.6% |
| Q3 2013 | $2,817,000 | +6.4% | 454,952 | -6.6% | 0.01% | 0.0% |
| Q2 2013 | $2,648,000 | – | 486,860 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
| ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
| Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
| Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
| NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
| Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
| Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
| First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
| DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
| RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |